MYX achieved its highest closing price since Jan 29th 2020.
With 99.4m short sold shares any hint of good news will cause a stampede of exiting shorters.
Shorters risks are all now to the upside.
There are now five major catalysts for a steep share price rise.
1. FDA approval for Nuvaring
2. FDA approval for E4
3. Strong operating cashflows in either H2 FY'20 or H1 FY'21
4. Announcement of resumption of dividend payments
5. Takeover offer
All five catalysts are alive and well. Imagine if all 5 were announced progressively over the next 12 months.
And i have not mentioned the huge US push to produce medicine, especially generics on US home soil.
MYX Price at posting:
46.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)